These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6989195)

  • 41. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
    Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
    Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
    [No Abstract]   [Full Text] [Related]  

  • 42. [Raubasine-peridural infiltration combination in therapy of obstructive arteriopathies of the lower extremities].
    Giubbolini G; Setacci C; Romei R; Federici L
    Minerva Cardioangiol; 1980 Mar; 28(3):177-82. PubMed ID: 7383367
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
    Liszewska D; Lukasik E
    Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of vasodilators in peripheral arterial insufficiency].
    Hansteen V; Lorentsen E
    Tidsskr Nor Laegeforen; 1971 Aug; 91(24):1731-4. PubMed ID: 5111131
    [No Abstract]   [Full Text] [Related]  

  • 45. [Evaluation of a single infusion of low-molecular dextran in patients with chronic obliterative arterial diseases].
    Chrzanowski W
    Pol Tyg Lek; 1969 Jul; 24(27):1057-9. PubMed ID: 4896578
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prostaglandin E1 in the treatment of chronic ischemia of the extremities].
    Kowal-Gierczak B; Kurzawska-Mielecka M; Czarnacki M
    Pol Arch Med Wewn; 1990 Nov; 84(5):321-7. PubMed ID: 2075125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Significance of prostaglandins in arterial thrombosis pathology: survey of an ongoing experience].
    Duvivier A; David JL
    Rev Med Liege; 1984 May; 39(9):354-61. PubMed ID: 6203155
    [No Abstract]   [Full Text] [Related]  

  • 48. Therapeutic potential of atrial natriuretic peptide administration on peripheral arterial diseases.
    Park K; Itoh H; Yamahara K; Sone M; Miyashita K; Oyamada N; Sawada N; Taura D; Inuzuka M; Sonoyama T; Tsujimoto H; Fukunaga Y; Tamura N; Nakao K
    Endocrinology; 2008 Feb; 149(2):483-91. PubMed ID: 17991722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease.
    Hossman V; Heinen A; Auel H; FitzGerald GA
    Thromb Res; 1981 May; 22(4):481-90. PubMed ID: 7027528
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of 1-4-dihydrazinophthalazine on arterial circulation of the limbs in normal and artery disease patients].
    Leoni E
    Gazz Int Med Chir; 1965 Sep; 69(17):1468-74. PubMed ID: 5837540
    [No Abstract]   [Full Text] [Related]  

  • 51. [First time hope for endangiitis patients].
    Keil TU
    Zahnarztl Mitt; 1989 Nov; 79(21):2462-3. PubMed ID: 2484145
    [No Abstract]   [Full Text] [Related]  

  • 52. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative study on the effects of nicergoline on muscular blood circulation in peripheral arterial diseases].
    Stancanelli V; Bagni B
    Minerva Cardioangiol; 1973 Sep; 21(9):581-4. PubMed ID: 4745001
    [No Abstract]   [Full Text] [Related]  

  • 54. Testosterone in the treatment of arterial insufficiency of the lower limbs.
    Hentzer E; Madsen PC
    Scand J Clin Lab Invest Suppl; 1967; 99():198-206. PubMed ID: 4862833
    [No Abstract]   [Full Text] [Related]  

  • 55. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
    Serra GC; Verlato R
    Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
    [No Abstract]   [Full Text] [Related]  

  • 56. [The use of intrathecal phenol solutions in vascular diseases of the lower exremities].
    Papo I; Visca A
    Minerva Cardioangiol; 1967 Feb; 15(2):169-71. PubMed ID: 5632412
    [No Abstract]   [Full Text] [Related]  

  • 57. [Arterial regional circulation of the lower extremities studied with the rheographic method and with albumin labeled with I-131].
    Modica G; Sorrentino F; Musco A
    Boll Soc Ital Cardiol; 1966; 11(4):1078-92. PubMed ID: 4867624
    [No Abstract]   [Full Text] [Related]  

  • 58. [Medical therapy of obliterating arteriopathies].
    Schwarz D
    Minerva Med; 1969 Oct; 60(87):4335-44. PubMed ID: 4242895
    [No Abstract]   [Full Text] [Related]  

  • 59. The influence of some drugs on platelet aggregation and adhesion.
    Bielawiec M; Perzanowski A; Myśliwiec M
    Acta Univ Carol Med Monogr; 1972; 53():211-4. PubMed ID: 4670729
    [No Abstract]   [Full Text] [Related]  

  • 60. Therapeutic effects of nitrendipine (Bayotensin) in patients with arteriosclerosis obliterans of lower limbs.
    Grodzińska L; Basista M; Ohlrogge R
    Prog Clin Biol Res; 1989; 301():423-7. PubMed ID: 2678132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.